Zobrazeno 1 - 10
of 1 427
pro vyhledávání: '"Van Soolingen, D."'
Autor:
Meehan, Conor J., Goig, G.A., Kohl, T.A., Verboven, L., Dippenaar, A., Ezewudo, M., Farhat, M.R., Guthrie, J.L., Laukens, K., Miotto, P., Ofori-Anyinam, B., Dreyer, V., Supply, P., Suresh, A., Utpatel, C., van Soolingen, D., Zhou, Y., Ashton, P.M., Brites, D., Cabibbe, A.M., de Jong, B.C., de Vos, M., Menardo, F., Gagneux, S., Gao, Q., Heupink, T.H., Liu, Q., Loiseau, C., Rigouts, L., Rodwell, T.C., Tagliani, E., Walker, T.M., Warren, R.M., Zhao, Y., Zignol, M., Schito, M., Gardy, J., Cirillo, D.M., Niemann, S., Comas, I., Van Rie, A.
Whole genome sequencing (WGS) of Mycobacterium tuberculosis has rapidly progressed from a research tool to a clinical application for the diagnosis and management of tuberculosis and in public health surveillance. This development has been facilitate
Externí odkaz:
http://hdl.handle.net/10454/17276
Autor:
Farhat, M.R., Freschi, L., Calderon, R., Ioerger, T., Snyder, M., Meehan, Conor J., de Jong, B.C., Rigouts, L., Sloutsky, A., Kaur, D., Sunyaev, S., van Soolingen, D., Shendure, J., Sacchettini, J., Murray, M.
Yes
Drug resistance diagnostics that rely on the detection of resistance-related mutations could expedite patient care and TB eradication. We perform minimum inhibitory concentration testing for 12 anti-TB drugs together with Illumina whole-geno
Drug resistance diagnostics that rely on the detection of resistance-related mutations could expedite patient care and TB eradication. We perform minimum inhibitory concentration testing for 12 anti-TB drugs together with Illumina whole-geno
Externí odkaz:
http://hdl.handle.net/10454/17274
Autor:
Machado, E., Vasconcellos, S.E.G., Cerdeira, C., Gomes, L.L., Junqueira, R., de Carvalho, L.D., Ramos, J.P., Redner, P., Campos, C.E.D., de Souza Caldas, P.C., Gomes, A.P.C.S., Goldenberg, T., Montes, F.F., de Queiroz Mello, F.C., de Oliveira Mussi, V., Lasunskaia, E., van Soolingen, D., de Miranda, A.B., Rigouts, L., de Jong, B.C., Meehan, Conor J., Catanho, M., Suffys, P.N.
Yes
Mycobacterium kansasii is an opportunistic pathogen and one of the most commonly encountered species in individuals with lung disease. We here report the complete genome sequence of 12 clinical isolates of M. kansasii from patients with pulm
Mycobacterium kansasii is an opportunistic pathogen and one of the most commonly encountered species in individuals with lung disease. We here report the complete genome sequence of 12 clinical isolates of M. kansasii from patients with pulm
Externí odkaz:
http://hdl.handle.net/10454/17573
Autor:
Gopie, F.A., Commiesie, E., Baldi, S., Kamst, M., Kaur, D., de Lange, W.C.M., Pinas, P.S., Stijnberg, D., Wongsokarijo, M., Zijlmans, C.W.R., de Zwaan, R., van Soolingen, D., Vreden, S.G.S., de Vries, G.
Publikováno v:
In Journal of Clinical Tuberculosis and Other Mycobacterial Diseases May 2021 23
Autor:
Nikolayevskyy, V., Niemann, S., Anthony, R., van Soolingen, D., Tagliani, E., Ködmön, C., van der Werf, M.J., Cirillo, D.M.
Publikováno v:
In Clinical Microbiology and Infection November 2019 25(11):1377-1382
Autor:
Brosch, R., Gordon, S. V., Marmiesse, M., Brodin, P., Buchrieser, C., Eiglmeier, K., Garnier, T., Gutierrez, C., Hewinson, G., Kremer, K., Parsons, L. M., Pym, A. S., Samper, S., van Soolingen, D., Cole, S. T.
Publikováno v:
Proceedings of the National Academy of Sciences of the United States of America, 2002 Mar . 99(6), 3684-3689.
Externí odkaz:
https://www.jstor.org/stable/3058187
Autor:
Vynnycky, E., Nagelkerke, N., Borgdorff, M. W., Van Soolingen, D., Van Embden, J. D. A., Fine, P. E. M.
Publikováno v:
Epidemiology and Infection, 2001 Feb 01. 126(1), 43-62.
Externí odkaz:
https://www.jstor.org/stable/3864766
Autor:
van Soolingen, D., Coutinho, R. A.
Publikováno v:
Clinical Infectious Diseases, 1997 Nov 01. 25(5), 1071-1077.
Externí odkaz:
https://www.jstor.org/stable/4460154
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Alffenaar, J W C, Stocker, S L, Forsman, L Davies, Garcia-Prats, A, Heysell, S K, Aarnoutse, R E, Akkerman, O W, Aleksa, A, van Altena, R, de Oñata, W Arrazola, Bhavani, P K, Van't Boveneind-Vrubleuskaya, N, Carvalho, A C C, Centis, R, Chakaya, J M, Cirillo, D M, Cho, J G, D Ambrosio, L, Dalcolmo, M P, Denti, P, Dheda, K, Fox, G J, Hesseling, A C, Kim, H Y, Köser, C U, Marais, B J, Margineanu, I, Märtson, A G, Torrico, M Munoz, Nataprawira, H M, Ong, C W M, Otto-Knapp, R, Peloquin, C A, Silva, D R, Ruslami, R, Santoso, P, Savic, R M, Singla, R, Svensson, E M, Skrahina, A, van Soolingen, D, Srivastava, S, Tadolini, M, Tiberi, S, Thomas, T A, Udwadia, Z F, Vu, D H, Zhang, W, Mpagama, S G, Schön, T, Migliori, G B
Publikováno v:
The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, vol 26, iss 6
International Journal of Tuberculosis and Lung Disease, 26, 6, pp. 483-499
International Journal of Tuberculosis and Lung Disease, 26, 483-499
International Journal of Tuberculosis and Lung Disease, 26(6), 483-499. International Union against Tubercul. and Lung Dis.
International Journal of Tuberculosis and Lung Disease, 26, 6, pp. 483-499
International Journal of Tuberculosis and Lung Disease, 26, 483-499
International Journal of Tuberculosis and Lung Disease, 26(6), 483-499. International Union against Tubercul. and Lung Dis.
BACKGROUND: Optimal drug dosing is important to ensure adequate response to treatment, prevent development of drug resistance and reduce drug toxicity. The aim of these clinical standards is to provide guidance on ‘best practice´ for dosing and ma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8aef5c7cecf38f14102fd039dc3e030b
https://escholarship.org/uc/item/59969461
https://escholarship.org/uc/item/59969461